192 related articles for article (PubMed ID: 25079197)
1. The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation in vitro: defining the stromal defect in myeloma.
Kassen D; Moore S; Percy L; Herledan G; Bounds D; Rodriguez-Justo M; Croucher P; Yong K
Br J Haematol; 2014 Oct; 167(2):194-206. PubMed ID: 25079197
[TBL] [Abstract][Full Text] [Related]
2. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow.
D'Ippolito G; Schiller PC; Ricordi C; Roos BA; Howard GA
J Bone Miner Res; 1999 Jul; 14(7):1115-22. PubMed ID: 10404011
[TBL] [Abstract][Full Text] [Related]
3. Myeloma impairs mature osteoblast function but causes early expansion of osteo-progenitors: temporal changes in bone physiology and gene expression in the KMS12BM model.
Kassen D; Lath D; Lach A; Evans H; Chantry A; Rabin N; Croucher P; Yong KL
Br J Haematol; 2016 Jan; 172(1):64-79. PubMed ID: 26767468
[TBL] [Abstract][Full Text] [Related]
4. Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation.
Aubin JE
J Cell Biochem; 1999 Mar; 72(3):396-410. PubMed ID: 10022521
[TBL] [Abstract][Full Text] [Related]
5. Osteoblast function in myeloma.
Roodman GD
Bone; 2011 Jan; 48(1):135-40. PubMed ID: 20601285
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
Baglìo SR; Devescovi V; Granchi D; Baldini N
Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
[TBL] [Abstract][Full Text] [Related]
8. Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.
Xu S; Evans H; Buckle C; De Veirman K; Hu J; Xu D; Menu E; De Becker A; Vande Broek I; Leleu X; Camp BV; Croucher P; Vanderkerken K; Van Riet I
Leukemia; 2012 Dec; 26(12):2546-9. PubMed ID: 22652628
[No Abstract] [Full Text] [Related]
9. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
[TBL] [Abstract][Full Text] [Related]
10. Bone Marrow Stress Decreases Osteogenic Progenitors.
Ng AH; Baht GS; Alman BA; Grynpas MD
Calcif Tissue Int; 2015 Nov; 97(5):476-86. PubMed ID: 26220824
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent decrease in the chondrogenic potential of human bone marrow mesenchymal stromal cells expanded with fibroblast growth factor-2.
Kanawa M; Igarashi A; Ronald VS; Higashi Y; Kurihara H; Sugiyama M; Saskianti T; Pan H; Kato Y
Cytotherapy; 2013 Sep; 15(9):1062-72. PubMed ID: 23800732
[TBL] [Abstract][Full Text] [Related]
12. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis.
Stenderup K; Justesen J; Eriksen EF; Rattan SI; Kassem M
J Bone Miner Res; 2001 Jun; 16(6):1120-9. PubMed ID: 11393789
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
14. Elevated tumor necrosis factor-alpha suppresses TAZ expression and impairs osteogenic potential of Flk-1+ mesenchymal stem cells in patients with multiple myeloma.
Li B; Shi M; Li J; Zhang H; Chen B; Chen L; Gao W; Giuliani N; Zhao RC
Stem Cells Dev; 2007 Dec; 16(6):921-30. PubMed ID: 17927494
[TBL] [Abstract][Full Text] [Related]
15. Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells -Implications for myeloma bone disease.
Dotterweich J; Schlegelmilch K; Keller A; Geyer B; Schneider D; Zeck S; Tower RJ; Ebert R; Jakob F; Schütze N
Bone; 2016 Dec; 93():155-166. PubMed ID: 27519972
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.
Yaccoby S; Wezeman MJ; Zangari M; Walker R; Cottler-Fox M; Gaddy D; Ling W; Saha R; Barlogie B; Tricot G; Epstein J
Haematologica; 2006 Feb; 91(2):192-9. PubMed ID: 16461303
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of bioactive polyvinylpyrrolidone-iodine within bilayered collagen scaffolds enhances the differentiation and subchondral osteogenesis of mesenchymal stem cells.
Jiang Y; Chen L; Zhang S; Tong T; Zhang W; Liu W; Xu G; Tuan RS; Heng BC; Crawford R; Xiao Y; Ouyang HW
Acta Biomater; 2013 Sep; 9(9):8089-98. PubMed ID: 23707501
[TBL] [Abstract][Full Text] [Related]
18. Human myeloma cells promote the recruitment of osteoblast precursors: mediation by interleukin-6 and soluble interleukin-6 receptor.
Karadag A; Scutt AM; Croucher PI
J Bone Miner Res; 2000 Oct; 15(10):1935-43. PubMed ID: 11028445
[TBL] [Abstract][Full Text] [Related]
19. Co-cultures of programmable cells of monocytic origin and mesenchymal stem cells do increase osteogenic differentiation.
Zachos C; Steubesand N; Seekamp A; Fuchs S; Lippross S
J Orthop Res; 2014 Oct; 32(10):1264-70. PubMed ID: 24961926
[TBL] [Abstract][Full Text] [Related]
20. The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro.
Shen B; Wei A; Whittaker S; Williams LA; Tao H; Ma DD; Diwan AD
J Cell Biochem; 2010 Feb; 109(2):406-16. PubMed ID: 19950204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
